DTa P vaccine

GPTKB entity

Statements (61)
Predicate Object
gptkbp:instance_of gptkb:vaccine
gptkbp:administered_by gptkb:children
intramuscular injection
gptkbp:age_group 4-6 years
6 months
2 months
4 months
15-18 months
gptkbp:associated_with Herd immunity
gptkbp:available_in liquid form
pre-filled syringes
gptkbp:booster_recommended every 10 years
gptkbp:clinical_trial conducted prior to approval
gptkbp:community_health reduces incidence of diseases
gptkbp:contains inactivated toxins
gptkbp:contraindication severe allergic reaction
progressive neurological disorder
gptkbp:developed_by gptkb:Sanofi_Pasteur
gptkbp:first_introduced gptkb:1991
https://www.w3.org/2000/01/rdf-schema#label DTa P vaccine
gptkbp:immunity_duration approximately 5-10 years
gptkbp:is_recommended_by gptkb:CDC
gptkb:WHO
gptkbp:is_vulnerable_to varies by provider
inactivated vaccine
part of routine immunization programs
important for public awareness
available in pharmacies
ongoing studies for new formulations
available in hospitals
available in clinics
updated periodically by health authorities
3 doses in infancy
booster dose in adolescence
booster dose in adulthood
booster dose in early childhood
conducted to monitor safety and effectiveness
high efficacy against diseases
significantly reduced disease rates
gptkbp:part_of childhood immunization schedule
gptkbp:produced_by multiple manufacturers
gptkbp:replaces DTP vaccine
gptkbp:safety_features generally safe
gptkbp:serves gptkb:diphtheria
tetanus
pertussis
gptkbp:side_effect fever
irritability
drowsiness
loss of appetite
local reaction at injection site
monitored post-licensure
gptkbp:storage refrigerated
gptkbp:type combination vaccine
gptkbp:vaccine_funding often covered by insurance
gptkbp:vaccine_policy mandated in many states
gptkbp:bfsParent gptkb:diphtheria
gptkb:diphtheria_toxoid
gptkb:tetanus_toxoid
gptkb:diphtheria-tetanus-pertussis_vaccine
gptkbp:bfsLayer 6